IRI Separation Technologies Inc.
TSX VENTURE : IRI

IRI Separation Technologies Inc.

February 29, 2008 09:00 ET

IRI Separation Technologies Inc. Announces a Change in Executive

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 29, 2008) - IRI Separation Technologies Inc. (TSX VENTURE:IRI) John Mason is pleased to announce that he is stepping down as President and CEO of IRI in favor of Rick Stiksma. Mr. Stiksma has held the position of CFO with the Company for the past two years, and his past work history includes 20 years in the egg industry at Vanderpol's Eggs Ltd., and 4 years as CEO of the Alberta Group. The Alberta Group was acquired by IRI in 2006.

"I'm excited to see Rick move into the President and CEO position. He has extensive industry knowledge, and knows the business inside and out. I'm confident that he will be able to lead the company through the next stage of growth, as production increases and sales contracts are completed," said Mr. Mason. Mr. Mason, who has held the position of Chairman, President and CEO of IRI since the company's inception in 2000 will continue to act as Chairman of IRI, remaining actively involved with the business, and devoting efforts to the company's long range planning activities.

About IRI Separation Technologies Inc.

IRI Separation Technologies Inc. (TSX VENTURE:IRI) is a biotechnology company that specializes in the extraction, development and commercialization of polyclonal immunoglobulin antibodies for virus and bacteria related health issues. Intended for use as a nutraceutical for human consumption, the antibodies are derived from chicken eggs. The immunoglobulin antibodies are intended for both the general and specific antibody market.

On behalf of the Board of Directors,

John Mason, Chairman

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information